• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素与替罗非班在微血管吻合术中的比较:大鼠模型中的随机对照试验。

Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model.

机构信息

Division of Otolaryngology-Head and Neck Surgery, University of Alberta, Edmonton, AB.

出版信息

J Otolaryngol Head Neck Surg. 2011 Feb;40 Suppl 1:S59-64.

PMID:21453663
Abstract

OBJECTIVE

Free flaps have become the mainstay of reconstruction after resection of head and neck cancer. Thrombosis after microvascular reanastamosis is a common reason for free flap failure. Various anticoagulants have been used topically and systemically to prevent thrombosis. Tirofiban is a glycoprotein IIb/IIIa inhibitor that prevents platelet aggregation and helps prevent thrombosis. The purpose of this study was to compare the thrombosis rate of topical heparin to topical heparin + tirofiban in a thrombogenic free flap model in rats.

STUDY DESIGN

Prospective, randomized, double-blind, controlled trial.

SUBJECTS AND METHODS

A thrombogenic free flap model was developed by raising a fasciocutaneous flap based on the epigastric artery in the Sprague-Dawley rat. An intimal flap was created proximal to the anastomosis site to increase thrombosis rates. Eighty rats were randomized to this thrombogenic free flap model using topical saline, heparin, or topical heparin + tirofiban. Each free flap was assessed for skin necrosis, capillary refill, and vessel thrombosis at 48 hours postprocedure. Data for each group were collected in a double-blind fashion.

RESULTS

The heparin + tirofiban group had a 23% lower thrombosis rate and hence free flap failure rate when compared to the heparin alone group (p  =  .044).

CONCLUSIONS

The use of topical tirofiban in addition to topical heparin in microvascular surgery results in reduced rates of thrombosis and should be considered for use in head and neck oncology patients undergoing free flap reconstruction.

摘要

目的

游离皮瓣已成为头颈部癌切除后重建的主要手段。微血管再吻合后的血栓形成是游离皮瓣失败的常见原因。各种抗凝剂已被用于局部和全身以预防血栓形成。替罗非班是一种糖蛋白 IIb/IIIa 抑制剂,可防止血小板聚集并有助于预防血栓形成。本研究旨在比较局部肝素与局部肝素+替罗非班在大鼠血栓形成游离皮瓣模型中的血栓形成率。

研究设计

前瞻性、随机、双盲、对照试验。

受试者和方法

通过在 Sprague-Dawley 大鼠的腹上动脉上掀起筋膜皮瓣,建立血栓形成的游离皮瓣模型。在吻合部位近端创建一个内膜瓣,以增加血栓形成率。80 只大鼠随机分为血栓形成的游离皮瓣模型,分别使用局部生理盐水、肝素或局部肝素+替罗非班。在术后 48 小时,每个游离皮瓣均评估皮肤坏死、毛细血管再充盈和血管血栓形成情况。每个组的数据均以双盲方式收集。

结果

与单独使用肝素组相比,肝素+替罗非班组的血栓形成率(即游离皮瓣失败率)降低了 23%(p=0.044)。

结论

在微血管手术中局部使用替罗非班加用局部肝素可降低血栓形成率,应考虑在头颈部肿瘤患者行游离皮瓣重建时使用。

相似文献

1
Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model.肝素与替罗非班在微血管吻合术中的比较:大鼠模型中的随机对照试验。
J Otolaryngol Head Neck Surg. 2011 Feb;40 Suppl 1:S59-64.
2
Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.使用阿司匹林、肝素和糖蛋白IIb/IIIa抑制剂替罗非班预防显微外科吻合口血栓形成。
Plast Reconstr Surg. 2007 Oct;120(5):1281-1288. doi: 10.1097/01.prs.0000279327.75083.ae.
3
The effect of tirofiban on microvascular thrombosis: crush model.替罗非班对微血管血栓形成的影响:挤压模型
Plast Reconstr Surg. 2005 Jul;116(1):205-8. doi: 10.1097/01.prs.0000169938.26534.97.
4
The outcome of microvascular free flap surgery with or without the use of postoperative heparin.使用或不使用术后肝素的微血管游离皮瓣手术的结果。
J Coll Physicians Surg Pak. 2014 Jun;24(6):412-5.
5
Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.低分子量肝素依诺肝素与血小板糖蛋白IIb/IIIa阻滞剂替罗非班联合用于非ST段抬高急性冠脉综合征患者的初步经验。
J Invasive Cardiol. 2000 Dec;12 Suppl E:E5-9;discussion E25-8.
6
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.不稳定型心绞痛或非Q波心肌梗死患者冠状动脉内血栓形成及替罗非班对血小板糖蛋白IIb/IIIa受体的阻断作用。PRISM-PLUS试验(对有不稳定体征和症状的患者进行缺血综合征管理的血小板受体抑制试验)的血管造影结果。PRISM-PLUS研究人员。
Circulation. 1999 Oct 12;100(15):1609-15. doi: 10.1161/01.cir.100.15.1609.
7
Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial).依替巴肽或替罗非班用于择期经皮冠状动脉介入治疗时依诺肝素与肝素的比较(ACTION试验)
Am J Cardiol. 2005 Jun 1;95(11):1295-301. doi: 10.1016/j.amjcard.2005.01.071.
8
Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.替罗非班与依诺肝素联合治疗急性冠脉综合征
Int J Cardiol. 1999 Dec 1;71(3):273-81. doi: 10.1016/s0167-5273(99)00171-0.
9
Comparison of outcome of microvascular bony head and neck reconstructions using the fibular free flap and the iliac crest flap.使用游离腓骨瓣和髂嵴瓣进行微血管性股骨头颈部重建的结果比较。
Br J Oral Maxillofac Surg. 2013 Sep;51(6):514-9. doi: 10.1016/j.bjoms.2013.01.007. Epub 2013 Feb 8.
10
Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.硫酸镁与血小板糖蛋白IIb/IIIa抑制剂替罗非班和依替巴肽在犬类支架血栓形成模型中的抗血栓作用比较
Circulation. 2002 Apr 23;105(16):1970-5. doi: 10.1161/01.cir.0000014612.88433.62.

引用本文的文献

1
Suppression of JAK2/STAT3 signaling reduces end-to-end arterial anastomosis induced cell proliferation in common carotid arteries of rats.抑制 JAK2/STAT3 信号通路可减少大鼠颈总动脉端端吻合诱导的细胞增殖。
PLoS One. 2013;8(3):e58730. doi: 10.1371/journal.pone.0058730. Epub 2013 Mar 14.